Form 3 - Initial statement of beneficial ownership of securities
2024年8月17日 - 7:57AM
Edgar (US Regulatory)
Exhibit
24
LIMITED
POWER OF ATTORNEY
KNOW
ALL BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints Phillip P. Chan as the undersigned’s true
and lawful attorney-in-fact (the “Attorney-in Fact”), with full power of substitution and resubstitution, with the power
to act alone for the undersigned and in the undersigned’s name, place and stead, in any and all capacities to:
(1) prepare,
execute in the undersigned’s name and on the undersigned’s behalf, and submit to the Securities and Exchange Commission (“SEC”)
a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling
the undersigned to make electronic filings with the SEC of reports required or considered advisable under Section 16(a) of
the Securities Exchange Act of 1934 (the “Exchange Act”) or any rule or regulation of the SEC;
(2) prepare,
execute and submit to the SEC, any national securities exchange and CytoSorbents Corporation (the “Company”) any and all
reports (including any amendment thereto) of the undersigned required or considered advisable under Section 16(a) of the Exchange
Act, and the rules and regulations thereunder, with respect to the equity securities of the Company, including Form 3 (Initial
Statement of Beneficial Ownership of Securities), Form 4 (Statement of Changes in Beneficial Ownership), and Form 5 (Annual
Statement of Changes in Beneficial Ownership); and
(3) seek
or obtain, as the undersigned's representative and on the undersigned's behalf, information regarding transactions in the Company's equity
securities from any third party, including the Company and any brokers, dealers, employee benefit plan administrators and trustees, and
the undersigned hereby authorizes any such third party to release any such information to the Attorney-in-Fact.
The
undersigned acknowledges that:
(1) this
Limited Power of Attorney authorizes, but does not require, the Attorney-in-Fact to act at his discretion on information provided to
such Attorney-in-Fact without independent verification of such information;
(2) any
documents prepared and/or executed by the Attorney-in-Fact on behalf of the undersigned pursuant to this Limited Power of Attorney will
be in such form and will contain such information as the Attorney-in- Fact, in his discretion, deems necessary or desirable;
(3) neither
the Company nor the Attorney-in-Fact assumes any liability for the undersigned's responsibility to comply with the requirements of Section 16
of the Exchange Act, any liability of the undersigned for any failure to comply with such requirements, or any liability of the undersigned
for disgorgement of profits under Section 16(b) of the Exchange Act; and
(4) this
Limited Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under
Section 16 of the Exchange Act, including, without, limitation, the reporting requirements under Section 16(a) of the
Exchange Act.
The
undersigned hereby grants to the Attorney-in-Fact full power and authority to do and perform each and every act and thing requisite,
necessary or convenient to be done in connection with the foregoing, as fully, to all intents and purposes, as the undersigned might
or could do in person, hereby ratifying and confirming all that the Attorney-in-Fact, or his substitute or substitutes, shall lawfully
do or cause to be done by authority of this Limited Power of Attorney.
This
Limited Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 or 5 with
respect to the undersigned's holdings of and transactions in equity securities of the Company, unless earlier revoked by the undersigned
in a signed writing delivered to the Attorney-in-Fact.
This
Limited Power of Attorney shall be governed by and construed in accordance the laws of the State of Delaware without regard to the laws
that might otherwise govern under applicable principles of conflicts of laws thereof.
[Signature
Page Follows]
IN
WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney to be executed as of this 16th day of August, 2024.
|
/s/ Peter J. Mariani |
|
Peter J. Mariani |
[Signature
Page to Power of Attorney (Mariani)]
CytoSorbents (NASDAQ:CTSO)
過去 株価チャート
から 7 2024 まで 8 2024
CytoSorbents (NASDAQ:CTSO)
過去 株価チャート
から 8 2023 まで 8 2024